lactic acid has been researched along with zoledronic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A; Manjappa, AS; Megraj Khandelwal, VK; Mishra, AK; Monkkonen, J; Ramachandra Murthy, RS; Ramanlal Chaudhari, K; Ukawala, M | 1 |
| Cooper-White, JJ; Fitzpatrick, J; Little, DG; Mikulec, K; Peacock, L; Ruys, AJ; Schindeler, A; Yu, NY | 1 |
| Cantrill, LC; Cooper-White, JJ; Fitzpatrick, J; Gdalevitch, M; Little, DG; Mikulec, K; Murphy, CM; Peacock, L; Ruys, AJ; Schindeler, A; Yu, NY | 1 |
3 other study(ies) available for lactic acid and zoledronic acid
| Article | Year |
|---|---|
Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel.
Topics: Animals; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Cell Line; Cell Line, Tumor; Diphosphonates; Docetaxel; Drug Carriers; Humans; Imidazoles; Lactic Acid; Mice; Nanoparticles; Neoplasm Metastasis; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids; Zoledronic Acid | 2012 |
Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation.
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Compressive Strength; Diphosphonates; Durapatite; Female; Imidazoles; Implants, Experimental; Lactic Acid; Mice; Mice, Inbred C57BL; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Porosity; Radiography; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta; Zoledronic Acid | 2013 |
Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents.
Topics: Animals; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Line; Diphosphonates; Femur; Guided Tissue Regeneration; Humans; I-kappa B Kinase; Imidazoles; Lactic Acid; Male; Osteoblasts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Tissue Scaffolds; Zoledronic Acid | 2014 |